- Tytuł:
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- Autorzy:
- Źródło:
- In The Lancet Neurology February 2019 18(2):165-176
Czasopismo naukowe